Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines
暂无分享,去创建一个
Pedro Alonso | Ogobara K. Doumbo | Robert W. Sauerwein | Marcel Tanner | Sumana Chakravarty | Stephen L. Hoffman | Robert A. Seder | Patrick E. Duffy | Peter G. Kremsner | S. Hoffman | O. Doumbo | M. Tanner | B. Mordmüller | P. Kremsner | P. Alonso | S. Abdulla | R. Sauerwein | K. Lyke | R. Seder | P. Billingsley | T. Richie | B. Sim | P. Duffy | S. Chakravarty | J. Epstein | E. James | Peter F. Billingsley | Judith E. Epstein | Thomas L. Richie | Kirsten E. Lyke | B. Kim Lee Sim | Salim Abdulla | Eric R. James | Benjamin Mordmüller
[1] W. Richards. Active Immunization of Chicks against Plasmodium gallinaceum by Inactivated Homologous Sporozoites and Erythrocytic Parasites , 1966, Nature.
[2] S. Hoffman,et al. Controlled Human Malaria Infection of Tanzanians by Intradermal Injection of Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites , 2014, The American journal of tropical medicine and hygiene.
[3] D. Herrington,et al. Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites. , 1990, Bulletin of the World Health Organization.
[4] P. F. Russell,et al. THE IMMUNIZATION OF FOWLS AGAINST MOSQUITO-BORNE PLASMODIUM GALLINACEUM BY INJECTIONS OF SERUM AND OF INACTIVATED HOMOLOGOUS SPOROZOITES , 1942, The Journal of experimental medicine.
[5] Myron M. Levine,et al. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites , 1987, Nature.
[6] D. Bj,et al. Tropical malaria contracted the natural way in the Netherlands , 1979 .
[7] J. Meuwissen,et al. Chloroquine sensitivity of isolates of Plasmodium falciparum adapted to in vitro culture. , 1981, Tropical and geographical medicine.
[8] G Losonsky,et al. Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites. , 1993, The Journal of infectious diseases.
[9] D. Carucci,et al. DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity , 2013, PloS one.
[10] S. Hoffman,et al. Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers under Chloroquine Prophylaxis: A Randomized Controlled Trial , 2016, The American journal of tropical medicine and hygiene.
[11] S. Hoffman,et al. Controlled Human Malaria Infections by Intradermal Injection of Cryopreserved Plasmodium falciparum Sporozoites , 2013, The American journal of tropical medicine and hygiene.
[12] S. Hoffman,et al. Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection , 2014, Front. Microbiol..
[13] S. Hoffman,et al. Optimizing Intradermal Administration of Cryopreserved Plasmodium falciparum Sporozoites in Controlled Human Malaria Infection , 2015, The American journal of tropical medicine and hygiene.
[14] Andrew Pollard,et al. DEATHS DURING MOUNTAINEERING AT EXTREME ALTITUDE , 1988, The Lancet.
[15] D. Clyde,et al. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. , 1975, The American journal of tropical medicine and hygiene.
[16] A. Folgori,et al. Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation , 2013, Nature Communications.
[17] Yuming Guo,et al. The effect of air pollution on human physiological function in China: a longitudinal study , 2015, The Lancet.
[18] S. Hoffman,et al. SAFETY AND EFFICACY OF A RECOMBINANT DNA PLASMODIUM FALCIPARUM SPOROZOITE VACCINE , 1987, The Lancet.
[19] S. Hoffman,et al. NF135.C10: A New Plasmodium falciparum Clone for Controlled Human Malaria Infections , 2012, The Journal of infectious diseases.
[20] S. Hoffman,et al. Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. , 1993, The American journal of tropical medicine and hygiene.
[21] S. C. T. P. Rts. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial , 2015, The Lancet.
[22] K. Sell,et al. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. , 1979, Bulletin of the World Health Organization.
[23] Patricia De la Vega,et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. , 2002, The Journal of infectious diseases.
[24] K. Rieckmann,et al. Human immunization with attenuated sporozoites. , 1990, Bulletin of the World Health Organization.
[25] S. Hoffman,et al. Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya , 2015, Malaria Journal.
[26] Adrian J F Luty,et al. Protection against a malaria challenge by sporozoite inoculation. , 2009, The New England journal of medicine.
[27] Jonathan E. Allen,et al. Genome sequence of the human malaria parasite Plasmodium falciparum , 2002, Nature.
[28] S. Hoffman,et al. A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoites , 2014, eLife.
[29] Clyde Df. Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971-75. , 1990 .
[30] K. Sell,et al. Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. , 1974, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[31] B. Delemarre,et al. [Tropical malaria contracted the natural way in the Netherlands]. , 1979, Nederlands tijdschrift voor geneeskunde.
[32] I. Kleinschmidt,et al. Five years of malaria control in the continental region, Equatorial Guinea , 2013, Malaria Journal.
[33] T. Burkot,et al. Infectivity to mosquitoes of Plasmodium falciparum clones grown in vitro from the same isolate. , 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[34] S. Hoffman,et al. Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates , 2015, Malaria Journal.
[35] S. Hoffman,et al. Two Plasmodium 6‐Cys family‐related proteins have distinct and critical roles in liver‐stage development , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] J. Weber,et al. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. , 1984, Science.
[37] D. Clyde,et al. Plasmodium vivax: correlation of circumsporozoite precipitation (CSP) reaction with sporozoite-induced protective immunity in man. , 1977, Experimental parasitology.
[38] J. Vanderberg,et al. Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei , 1967, Nature.
[39] V. Nussenzweig,et al. Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. , 1979, Bulletin of the World Health Organization.
[40] D. Clyde. Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971-75. , 1990, Bulletin of the World Health Organization.
[41] Jonathan Crabtree,et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax , 2008, Nature.
[42] S. Hoffman,et al. Optimising Controlled Human Malaria Infection Studies Using Cryopreserved P. falciparum Parasites Administered by Needle and Syringe , 2013, PloS one.
[43] R. Sauerwein,et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study , 2011, The Lancet.
[44] J. Vanderberg,et al. Immunization of man against sporozite-induced falciparum malaria , 1973, The American journal of the medical sciences.
[45] S. Hoffman,et al. Comparative cost models of a liquid nitrogen vapor phase (LNVP) cold chain-distributed cryopreserved malaria vaccine vs. a conventional vaccine. , 2013, Vaccine.
[46] S. Hoffman,et al. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres , 2015, Malaria Journal.
[47] Peter G. Kremsner,et al. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. , 2015 .
[48] Mario Roederer,et al. Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine , 2013, Science.
[49] R. Miller,et al. Specificity of protection of man immunized against sporozoite‐induced falciparum malaria , 1973, The American journal of the medical sciences.
[50] Sumana Chakravarty,et al. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria , 2010, Human vaccines.
[51] S. Hoffman,et al. The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria. , 2009, The Journal of infectious diseases.
[52] E. R. James,et al. Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity , 2011, Science.
[53] P. F. Russell,et al. Active Immunization of Fowls against Sporozoites but not Trophozoltes of Plasmodium gallinaceum by Injections of Homologous Sporozoites. , 1942 .